Chin is both winning and losing its battle with OMICRON. On one hand, case numbers are falling:
But they can’t stamp it out and Beijing is now being drawn into lockdowns.
On the other hand, the economic spillovers are mounting:
Advertisement
Chin is both winning and losing its battle with OMICRON. On one hand, case numbers are falling:
But they can’t stamp it out and Beijing is now being drawn into lockdowns.
On the other hand, the economic spillovers are mounting:
The full text of this article is available to MacroBusiness subscribers